BSE filing, BSE: 544895. Summary written from the filing by ALFA Finder's alert engine.
Kwick Forensic Solutions Ltd: key numbers
- Share price
- ₹177.00
- Market cap
- ₹379.4 Cr
- Revenue (annual)
- ₹105.7 Cr
- Net profit (annual)
- ₹13.51 Cr
- P/E (TTM)
- 28.1×Sector 36.4×
- Promoter holding
- 64.65%
- FII holding
- 0.52%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kwick Forensic Solutions Ltd
All →Kwick Forensic Solutions Price Movement Clarification
Kwick Forensic Solutions confirmed no undisclosed price-sensitive information caused its recent price movement. The company attributed the movement to market forces alone.
Kwick Forensic Solutions Investor Presentation: Key Takeaways
Kwick Forensic provides integrated digital/physical forensic solutions. Presentation highlights historical FY24-FY26 growth, R&D capabilities, and expanded product portfolio including 'E-Forensics' suite.
Kwick Forensic Solutions Other Announcement
Kwick Forensic Solutions issued a press release regarding the ₹150 Crore NFSU campus development, noting potential future opportunities for the industry without any specific company order.
Kwick Forensic Solutions Business Update
Kwick Forensic Solutions noted emerging opportunities following the government's development of a ₹150 crore National Forensic Sciences University campus in Varanasi.
Kwick Forensic Solutions Price Movement Clarification
Kwick Forensic Solutions responded to a BSE query regarding recent stock price movement. The company confirmed it is unaware of any material information causing the fluctuation.
Kwick Forensic Solutions Other Announcement
Kwick Forensic Solutions Ltd has filed its shareholding pattern report for the quarter ended September 2026. This disclosure provides details of shareholding across various investor categories.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.